These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36776066)

  • 1. Multiple Adipokines Predict Dementia Severity as Measured by δ: Replication Across Biofluids and Cohorts.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2023; 92(2):639-652. PubMed ID: 36776066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based protein predictors of dementia severity as measured by δ: Replication across biofluids and cohorts.
    Royall DR; Bishnoi RJ; Palmer RF;
    Alzheimers Dement (Amst); 2019 Dec; 11():763-774. PubMed ID: 31909176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative.
    Royall DR; Palmer RF;
    J Alzheimers Dis; 2019; 67(1):67-79. PubMed ID: 30507569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-based protein mediators of senility with replications across biofluids and cohorts.
    Royall DR; Palmer RF;
    Brain Commun; 2020; 2(1):fcz036. PubMed ID: 32954311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope.
    Palmer RF; Royall DR
    J Alzheimers Dis; 2016; 49(2):521-9. PubMed ID: 26444763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. δ Scores are Exportable Across Cultural and Linguistic Boundaries.
    Royall DR; Palmer RF; Matsuoka T; Kato Y; Taniguchi S; Ogawa M; Fujimoto H; Okamura A; Shibata K; Nakamura K; Nakaaki S; Koumi H; Mimura M; Fukui K; Narumoto J
    J Alzheimers Dis; 2016; 49(2):561-70. PubMed ID: 26444764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2019; 70(1):199-210. PubMed ID: 31127788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    Letra L; Matafome P; Rodrigues T; Duro D; Lemos R; Baldeiras I; Patrício M; Castelo-Branco M; Caetano G; Seiça R; Santana I
    J Alzheimers Dis; 2019; 67(2):725-735. PubMed ID: 30689587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Adiponectin is Related to Dementia.
    Benavente KSK; Palmer RF; Royall DR
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):779-783. PubMed ID: 31112230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.
    Royall DR; Palmer RF; Markides KS
    J Gerontol B Psychol Sci Soc Sci; 2017 Oct; 72(6):947-955. PubMed ID: 26968639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology.
    Kim KY; Ha J; Kim M; Cho SY; Kim H; Kim E;
    Alzheimers Res Ther; 2022 Nov; 14(1):165. PubMed ID: 36329496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites.
    Royall DR; Palmer RF
    Alzheimers Dement (Amst); 2016; 3():35-42. PubMed ID: 27239547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Welcome Back to Your Future: The Assessment of Dementia by the Latent Variable "δ".
    Royall DR
    J Alzheimers Dis; 2016; 49(2):515-9. PubMed ID: 26444759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.